Saxo Bank has officially announced the end of its independent anti-doping programme with Danish company Clearidium and its head, Dr. Rasmus Damsgaard. The three-year cooperation has come to a close because of the potential conflict of interest posed by Clearidium’s forthcoming involvement with the International Cycling Union’s (UCI) blood passport programme. Clearidium has conducted internal controls for Saxo Bank since 2006. The team’s riders have been subject to a 12 blood profiles, 4 steroid …

Excerpt from: 
Saxo Bank ends independent testing programme